Domenico Lepore

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

Andreas Stahl, Domenico Lepore, Alistair R. Fielder et al. · The Lancet · 2019 · 411 citations · Full text

Ocular Disease, Neonatology, Ophthalmology +6

Intravitreal Bevacizumab versus Laser Treatment in Type 1 Retinopathy of Prematurity

Domenico Lepore, Graham E. Quinn, Fernando Molle et al. · Ophthalmology · 2014 · 184 citations

Type 1, Ocular Disease, Vitreous Body +8

Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity

Andreas Stahl, Emine Alyamaç Sukgen, Wei‐Chi Wu et al. · JAMA · 2022 · 128 citations · Full text

Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings

Domenico Lepore, Graham E. Quinn, Fernando Molle et al. · Ophthalmology · 2017 · 127 citations

Type 1, Ocular Disease, Fluorescein Angiographic Findings +6

Atlas of Fluorescein Angiographic Findings in Eyes Undergoing Laser for Retinopathy of Prematurity

Domenico Lepore, Fernando Molle, Monica Maria Pagliara et al. · Ophthalmology · 2010 · 110 citations

Eyes Undergoing Laser, Ocular Disease, Vitreous Body +6